ADMA Biologics, Inc.ADMANASDAQ
Loading
Year-over-year research & development expense growth
5Y CAGR
+1.4%/yr
Long-term compound
Percentile
P93
Near historical high
vs 5Y Ago
1.1x
Modest growth
Streak
1 yr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| 2025 | 162.66% |
| 2024 | -45.06% |
| 2023 | -8.69% |
| 2022 | -0.88% |
| 2021 | -38.28% |
| 2020 | 152.02% |
| 2019 | -40.30% |
| 2018 | -36.98% |
| 2017 | -18.97% |
| 2016 | 9.58% |